Targeting Hippo components directly seems to be a feasible strategy to regulate the Hippo pathway It has been shown that the selective MST1/2 inhibitor XMU-MP-1 stimulates YAP activation, which in turn promotes cell proliferation and tissue repair and regeneration (53), but its anti-tumor effect needs further study. This evidence concerns the gene YAP1 and neoplasm.